Garrison Michael David (CIK 1944816) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-25). Recent activity: Sell BDX (1,100 shares), Sell BDX (1,100 shares), Buy BDX (3,054 shares), Sell BDX (2,454 shares), Sell BDX (600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-25 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Sell | 1,100 | $160,226 |
| 2026-06-11 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Sell | 1,100 | $166,628 |
| 2026-01-16 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Buy | 3,054 | $512,797 |
| 2026-01-16 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Sell | 2,454 | $512,886 |
| 2026-01-16 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Sell | 600 | $125,400 |
| 2026-01-16 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Sell | 1,010 | $208,605 |
| 2025-12-17 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Sell | 629 | $123,303 |
| 2025-12-01 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Buy | 7,568 | $0 |
| 2025-12-01 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Buy | 3,048 | $0 |
| 2025-12-01 | BECTON DICKINSON & CO (BDX) | EVP & Pres Med.Essntl&BioPharm | Sell | 1,769 | $0 |
| 2025-07-22 | BECTON DICKINSON & CO (BDX) | EVP & President, Medical | Buy | 6,360 | $939,245 |
| 2025-07-22 | BECTON DICKINSON & CO (BDX) | EVP & President, Medical | Sell | 5,175 | $933,001 |
| 2025-07-22 | BECTON DICKINSON & CO (BDX) | EVP & President, Medical | Sell | 1,184 | $213,463 |
| 2025-07-22 | BECTON DICKINSON & CO (BDX) | EVP & President, Medical | Sell | 1 | $182 |
| 2025-04-10 | BECTON DICKINSON & CO (BDX) | EVP & President, Medical | Sell | 479 | $94,497 |
| 2025-03-04 | BECTON DICKINSON & CO (BDX) | EVP & President Medical | Sell | 178 | $0 |
| 2025-01-21 | BECTON DICKINSON & CO (BDX) | EVP & President, Medical | Sell | 597 | $141,196 |
Source: SEC Form 4 filings · as of 2026-06-25